We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Sets out the payment due from members of the voluntary scheme for branded medicines pricing, access and growth in 2026.
Actions QPs, RPis and RPs need to take following agreement of the Windsor Framework
Supplementary information on the licensing of medicines for human use in the UK following the agreement of the Windsor Framework.
Recommendations for prescribing methadone and buprenorphine to people in treatment for opioid dependence in England.
A 5-year deal setting out how community pharmacy will support delivery of the NHS Long Term Plan.
A poster explaining the different symbols used on medical devices.
Guidance on infant and follow-on formula, the application form for infant and follow-on formula made from protein hydrolysates, and forms to notify the authority.
How the MHRA makes decisions on whether a borderline product is a medical device and whether medical devices regulations should apply.
Resources for World Antimicrobial Resistance Awareness Week (WAAW) and European Antibiotic Awareness Day (EAAD) for healthcare professionals in England.
The locations for a Marketing Authorisation Holder (MAH) and a Qualified Person responsible for Pharmacovigilance (QPPV)
Every year the MHRA receives requests for its staff to speak at conferences and other events across the world.
This is a work sharing model for the co-ordinated assessment of a generic application that has been filed with multiple Access Consortium agencies.
Reforms to ensure that medical device regulation is fit for purpose for software products, including artificial intelligence (AI).
10 guiding principles that can inform the development of good machine learning practice (GMLP).
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore research and technology development of relevance to the modelling of traumatic wounds and the monitoring of their progression.
Approved countries for batch testing and importation of medicines
Guiding principles for the use of predetermined change control plans (PCCPs) for managing rapid product changes in medical devices.
Information for manufacturers on the regulations that apply to prosthetic, orthotic and ophthalmic devices.
A proposed format to help prepare responses to good distribution practice (GDP)/good manufacturing practice (GMP) post inspection letters.
Information for people who wish to apply to release a vaccine or a blood product to market in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).